Citation, DOI, disclosures and article data
At the time the article was created Henry Knipe had no recorded disclosures.View Henry Knipe's current disclosures
At the time the article was last revised Daniel J Bell had no recorded disclosures.View Daniel J Bell's current disclosures
Hepatic osteodystrophy is an often forgotten metabolic bone disease seen in patients with chronic liver disease, in particular cirrhosis, primary biliary cholangitis, and primary sclerosing cholangitis.
Cirrhotic patients have increased risk factors for developing osteoporosis such as hypogonadism, alcohol and steroid use, vitamin D deficiency, and low body mass index. Other factors that contribute include poor intestinal cholecalciferol absorption, impaired vitamin D activation and hyperbilirubinemia which can diminish osteoblastic function 4.
- 1. López-Larramona G, Lucendo AJ, González-Castillo S et-al. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol. 2011;3 (12): 300-7. doi:10.4254/wjh.v3.i12.300 - Free text at pubmed - Pubmed citation
- 2. Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol. 2010;31 (2): 82-6. Pubmed citation
- 3. Idilman R, de Maria N, Uzunalimoglu O et-al. Hepatic osteodystrophy: a review. Hepatogastroenterology. 1997;44 (14): 574-81. Pubmed citation
- 4. Arora A, Rajesh S, Bansal K, Sureka B, Patidar Y, Thapar S, Mukund A. Cirrhosis-related musculoskeletal disease: radiological review. (2016) The British journal of radiology. 89 (1066): 20150450. doi:10.1259/bjr.20150450 - Pubmed